Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|May 30, 2024
Mast cell degranulation and bradykinin-induced angioedema - searching for the missing linkGrzegorz Porebski, Alicja Dziadowiec, Hubert Rybka, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Effect of Selected Silyl Groups on the Anticancer Activity of 3,4-Dibromo-5-Hydroxy-Furan-2(5H)-One DerivativesRadoslaw Kitel, Anna Byczek-Wyrostek, Katarzyna Hopko, et al.
European Journal of Medicinal Chemistry|March 24, 2018
Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluationAnna Byczek-Wyrostek, Radoslaw Kitel, Klaudia Rumak, et al.
Expert Opinion on Therapeutic Patents|June 21, 2024
An updated patent review on PD-1/PD-L1 antagonists (2022-present)Wiktor Uzar, Beata Kaminska, Hubert Rybka, et al.
Molecules (Basel, Switzerland)|December 11, 2022
Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 ProteinAtilio Reyes Romero, Katarzyna Kubica, Radoslaw Kitel, et al.
Molecules (Basel, Switzerland)|June 27, 2024
Correction: Reyes Romero et al. Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein. Molecules 2022, 27, 8282Atilio Reyes Romero, Katarzyna Kubica, Radoslaw Kitel, et al.
Structure (London, England : 1993)|November 26, 2015
Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1Krzysztof M Zak, Radoslaw Kitel, Sara Przetocka, et al.
International Journal of Molecular Sciences|November 13, 2021
PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of ActionEwa Surmiak, Katarzyna Magiera-Mularz, Bogdan Musielak, et al.
Scientific Reports|March 19, 2022
Analysis tools for single-monomer measurements of self-assembly processesMaria Hoyer, Alvaro H Crevenna, Radoslaw Kitel, et al.
Frontiers in Pharmacology|September 17, 2025
The prevalence of genetic variants of the Mas-related G-protein-coupled receptor X2 in patients does not explain perioperative hypersensitivity reactions to neuromuscular blocking agentsAlicja Dziadowiec, Mateusz Kwitniewski, Peter Kopac, et al.
Pageof 2